BWX Technologies stock barely flinched after earnings, slipping about 1% even as the company posted another quarter that leaned more bullish than the chart suggests. Q2 revenue came in around US$902m with solid growth in its nuclear-focused businesses, and adjusted earnings per share reached US$1.07. Free cash flow of US$115m and a 40% jump in backlog to US$8.4b indicate demand that appears stronger than the recent 30 day and 90 day share price declines would imply.

Is BWX Technologies stock simply expensive on headlines, or does the earnings and backlog story justify a premium multiple at this price? Compare the current P/E, cash flows, and growth assumptions in the valuation analysis for BWX Technologies.

Q2 2026 Earnings Summary

…